Efficacy of colchicine for stroke prevention: a meta-analysis of CHANCE-3 and CONVINCE
VJNeurology
Efficacy of colchicine for stroke prevention: a meta-analysis of CHANCE-3 and CONVINCE
5:16
Glucagon-like peptide-1 receptor agonist use and outcomes in patients with cardiac amyloidosis
VJNeurology
Glucagon-like peptide-1 receptor agonist use and outcomes in patients with cardiac amyloidosis
4:48
Understanding the re-canalization paradox in vertebrobasilar occlusions
VJNeurology
Understanding the re-canalization paradox in vertebrobasilar occlusions
3:18
Advances in pediatric stroke research
VJNeurology
Advances in pediatric stroke research
0:53
The role of the multi-disciplinary team in improving the treatment of post-stroke vision impairment
VJNeurology
The role of the multi-disciplinary team in improving the treatment of post-stroke vision impairment
2:53
Women in medicine: breaking stereotypes and barriers
VJNeurology
Women in medicine: breaking stereotypes and barriers
3:18
The current management of post-stroke vision impairments
VJNeurology
The current management of post-stroke vision impairments
2:09
ISC 2025 | Trials investigating medium and distal vessel occlusions and other meeting highlights
VJNeurology
ISC 2025 | Trials investigating medium and distal vessel occlusions and other meeting highlights
1:51
The prevalence and etiology of pediatric stroke
VJNeurology
The prevalence and etiology of pediatric stroke
1:43
Neuroprotective strategies to improve functional outcomes in acute ischemic stroke
VJNeurology
Neuroprotective strategies to improve functional outcomes in acute ischemic stroke
2:14
China's experience with urokinase thrombolysis for acute ischemic stroke (AIS)
VJNeurology
China's experience with urokinase thrombolysis for acute ischemic stroke (AIS)
10:35
A meta-analysis of the efficacy of GLP-1 receptor agonists in the prevention of stroke
VJNeurology
A meta-analysis of the efficacy of GLP-1 receptor agonists in the prevention of stroke
6:08
Intra-arterial thrombolytics after endovascular thrombectomy in acute ischemic stroke
VJNeurology
Intra-arterial thrombolytics after endovascular thrombectomy in acute ischemic stroke
1:12
The future of thrombolytic therapy for medium vessel occlusion stroke
VJNeurology
The future of thrombolytic therapy for medium vessel occlusion stroke
1:31
Outcomes of CD19-directed CAR T-cell therapy in five individuals with multiple sclerosis
VJNeurology
Outcomes of CD19-directed CAR T-cell therapy in five individuals with multiple sclerosis
5:02
Emerging approaches for the secondary prevention of stroke: anti-inflammatory therapies and more
VJNeurology
Emerging approaches for the secondary prevention of stroke: anti-inflammatory therapies and more
4:00
Contemporary trends in treatment and outcomes of AIS: an analysis of the Florida Stroke Registry
VJNeurology
Contemporary trends in treatment and outcomes of AIS: an analysis of the Florida Stroke Registry
11:38
Characteristics of mild strokes with a target occlusion: preliminary analysis of TRIMIS
VJNeurology
Characteristics of mild strokes with a target occlusion: preliminary analysis of TRIMIS
14:02
FAST-Kids: Achieving Fast Assessment and Stroke Triage in Kids
VJNeurology
FAST-Kids: Achieving Fast Assessment and Stroke Triage in Kids
2:58
Major unmet needs in the treatment of stroke
VJNeurology
Major unmet needs in the treatment of stroke
4:18
Wrap-up of ISC 2025 with the Chair and Vice Chair
VJNeurology
Wrap-up of ISC 2025 with the Chair and Vice Chair
3:08
The development of the AHA Skilled Nursing Facility Stroke Rehabilitation Certification
VJNeurology
The development of the AHA Skilled Nursing Facility Stroke Rehabilitation Certification
6:51
The impact of age and collateral status on outcomes of vertebrobasilar artery occlusion
VJNeurology
The impact of age and collateral status on outcomes of vertebrobasilar artery occlusion
2:36
Intravenous tirofiban as an adjunct to EVT in posterior circulation strokes with tandem lesions
VJNeurology
Intravenous tirofiban as an adjunct to EVT in posterior circulation strokes with tandem lesions
7:24
The progression and recovery of vision after stroke
VJNeurology
The progression and recovery of vision after stroke
2:25
Visual deficits after stroke: visual field impairment and visual neglect
VJNeurology
Visual deficits after stroke: visual field impairment and visual neglect
1:59
Treatment with intravenous alteplase in AIS with onset time between 4.5 and 24 hours
VJNeurology
Treatment with intravenous alteplase in AIS with onset time between 4.5 and 24 hours
5:55
A comparison of FAST and BE-FAST performance in stroke detection by the general public
VJNeurology
A comparison of FAST and BE-FAST performance in stroke detection by the general public
7:59
Findings from the TRANSPORT 2 study: tDCS with CIMT for post-stroke motor recovery
VJNeurology
Findings from the TRANSPORT 2 study: tDCS with CIMT for post-stroke motor recovery
7:40
Early antiplatelet therapy following intravenous thrombolysis for acute ischemic stroke: TREND-IVT
VJNeurology
Early antiplatelet therapy following intravenous thrombolysis for acute ischemic stroke: TREND-IVT
6:28
RECAST-MT: RIC for acute ischemic stroke treated with mechanical thrombectomy
VJNeurology
RECAST-MT: RIC for acute ischemic stroke treated with mechanical thrombectomy
6:56
Addressing the unmet needs in ICH: the bundle of care and trans-sulcal approach
VJNeurology
Addressing the unmet needs in ICH: the bundle of care and trans-sulcal approach
2:47
Unmet needs in the secondary prevention of stroke in patients with atrial fibrillation
VJNeurology
Unmet needs in the secondary prevention of stroke in patients with atrial fibrillation
3:32
Endovascular therapy in medium vessel occlusion stroke: findings from the DISTAL trial
VJNeurology
Endovascular therapy in medium vessel occlusion stroke: findings from the DISTAL trial
3:59
Key trials to look out for at ISC 2025: PRESTIGE-AF and DISTAL
VJNeurology
Key trials to look out for at ISC 2025: PRESTIGE-AF and DISTAL
2:45
A multi-center study on the effectiveness of the Daytime-Nighttime Appliance for OSA treatment
VJNeurology
A multi-center study on the effectiveness of the Daytime-Nighttime Appliance for OSA treatment
2:01
Recommendations for neurologists treating patients with RLS
VJNeurology
Recommendations for neurologists treating patients with RLS
1:56
Mitigating the risk of iron overload in patients with RLS treated with iron supplementation
VJNeurology
Mitigating the risk of iron overload in patients with RLS treated with iron supplementation
2:03
The relationship between RLS and cognitive impairment
VJNeurology
The relationship between RLS and cognitive impairment
1:01
The current approaches to managing pediatric sleep disturbances
VJNeurology
The current approaches to managing pediatric sleep disturbances
1:35
Current limitations in pediatric sleep research and treatment
VJNeurology
Current limitations in pediatric sleep research and treatment
6:45
The impact of a changing society on pediatric sleep
VJNeurology
The impact of a changing society on pediatric sleep
7:07
Current perspectives on the management of CSA
VJNeurology
Current perspectives on the management of CSA
2:34
Implementing applications of circadian health in public institutions and society
VJNeurology
Implementing applications of circadian health in public institutions and society
1:48
Advancing the understanding of narcolepsy pathology to improve patient quality of life
VJNeurology
Advancing the understanding of narcolepsy pathology to improve patient quality of life
1:47
Recommendations of the European guidelines on the accreditation of sleep medicine centers
VJNeurology
Recommendations of the European guidelines on the accreditation of sleep medicine centers
2:04
Overlapping feature of disturbed sleep across several neurological disorders
VJNeurology
Overlapping feature of disturbed sleep across several neurological disorders
2:13
The role ultra-long-term EEG data may play in understanding the interplay of epilepsy and sleep
VJNeurology
The role ultra-long-term EEG data may play in understanding the interplay of epilepsy and sleep
1:19
The importance of early surgery in pediatric epilepsies
VJNeurology
The importance of early surgery in pediatric epilepsies
1:20
The need for technological solutions for objective long-term monitoring of epileptic seizures
VJNeurology
The need for technological solutions for objective long-term monitoring of epileptic seizures
1:51
Highlights in the field of epilepsy surgery from EEC 2024
VJNeurology
Highlights in the field of epilepsy surgery from EEC 2024
1:01
Challenges in validating a clinical prediction model of seizure risk in patients with epilepsy
VJNeurology
Challenges in validating a clinical prediction model of seizure risk in patients with epilepsy
2:48
Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
VJNeurology
Focal cortical stimulation with the EASEE system for pharmacoresistant focal epilepsy
7:51
VNS versus DBS for drug-resistant epilepsy
VJNeurology
VNS versus DBS for drug-resistant epilepsy
3:44
The need for a seizure prediction tool to optimize epilepsy treatment
VJNeurology
The need for a seizure prediction tool to optimize epilepsy treatment
1:35
Enhancing the use of advanced MRI in MS diagnosis and monitoring
VJNeurology
Enhancing the use of advanced MRI in MS diagnosis and monitoring
1:24
Promoting sustainability in healthcare & considering the environmental impact of congress travel
VJNeurology
Promoting sustainability in healthcare & considering the environmental impact of congress travel
1:33
What should be done in pregnancy for pts with myasthenia gravis & unanswered questions that remain
VJNeurology
What should be done in pregnancy for pts with myasthenia gravis & unanswered questions that remain
1:22
Novel agents being explored for the treatment of CIDP
VJNeurology
Novel agents being explored for the treatment of CIDP
2:22
Investigating CAR T-cell therapy in the treatment of MS
VJNeurology
Investigating CAR T-cell therapy in the treatment of MS
2:14
Improving the assessment of patients with MG: monitoring QoL & psychiatric comorbidities
VJNeurology
Improving the assessment of patients with MG: monitoring QoL & psychiatric comorbidities
2:35
Results of a Phase IIa trial investigating rozanolixizumab for CIDP
VJNeurology
Results of a Phase IIa trial investigating rozanolixizumab for CIDP
1:31
Initiatives and activities of the RRFS
VJNeurology
Initiatives and activities of the RRFS
2:51
Trials investigating the complement inhibitor riliprubart for treating CIDP
VJNeurology
Trials investigating the complement inhibitor riliprubart for treating CIDP
4:22
An umbrella review of early mobilization decision after acute stroke
VJNeurology
An umbrella review of early mobilization decision after acute stroke
2:00
Impact of sleep disturbances on neuropsychiatric symptoms in AD
VJNeurology
Impact of sleep disturbances on neuropsychiatric symptoms in AD
2:02
Using digital tools in rare brain disorders: benefits, drawbacks, & patient perspectives
VJNeurology
Using digital tools in rare brain disorders: benefits, drawbacks, & patient perspectives
11:09
Developing a training course for HCPs who use brain stimulation techniques
VJNeurology
Developing a training course for HCPs who use brain stimulation techniques
1:49
Developing the SynNeurGe criteria for use in Parkinson's research
VJNeurology
Developing the SynNeurGe criteria for use in Parkinson's research
5:31
The mechanisms behind orthostatic hypotension in pure autonomic failure
VJNeurology
The mechanisms behind orthostatic hypotension in pure autonomic failure
1:44
The potential of circular RNAs as novel biomarkers in Parkinson's disease
VJNeurology
The potential of circular RNAs as novel biomarkers in Parkinson's disease
2:27
The importance of early intervention and long-term treatment in patients with epilepsy
VJNeurology
The importance of early intervention and long-term treatment in patients with epilepsy
1:23
The challenges with implementing transcranial electrical brain stimulation into clinical practice
VJNeurology
The challenges with implementing transcranial electrical brain stimulation into clinical practice
2:31
Predicting clinical outcomes of patients with Parkinson's who received deep brain stimulation
VJNeurology
Predicting clinical outcomes of patients with Parkinson's who received deep brain stimulation
1:45
The new Sleep Environmental Factors (SEF) measure for assessing factors influencing sleep hygiene
VJNeurology
The new Sleep Environmental Factors (SEF) measure for assessing factors influencing sleep hygiene
7:19
The latest developments in the treatment of RLS
VJNeurology
The latest developments in the treatment of RLS
2:19
Using an under-mattress monitoring device to study the prevalence of sleep apnea
VJNeurology
Using an under-mattress monitoring device to study the prevalence of sleep apnea
2:33
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
VJNeurology
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
1:40
The effects of a comprehensive rehabilitation program for patients with narcolepsy
VJNeurology
The effects of a comprehensive rehabilitation program for patients with narcolepsy
3:38
Types of consumer sleep monitoring devices and their role in improving the diagnosis of sleep apnea
VJNeurology
Types of consumer sleep monitoring devices and their role in improving the diagnosis of sleep apnea
1:35
Incorporating new developments in RLS into clinical guidelines
VJNeurology
Incorporating new developments in RLS into clinical guidelines
2:08
The need for further studies investigating the benefit of chronomedicine
VJNeurology
The need for further studies investigating the benefit of chronomedicine
1:24
A study investigating imagery rescripting as a technique to treat insomnia
VJNeurology
A study investigating imagery rescripting as a technique to treat insomnia
3:45
Gender-specific patterns of sleep in children and the potential role in psychiatric disorders
VJNeurology
Gender-specific patterns of sleep in children and the potential role in psychiatric disorders
5:16
The implementation of the new MS diagnostic criteria into clinical practice
VJNeurology
The implementation of the new MS diagnostic criteria into clinical practice
2:57
Improving the global applicability of the new MS diagnostic criteria
VJNeurology
Improving the global applicability of the new MS diagnostic criteria
1:49
How a better understanding of RAW and PIRA may improve outcomes & therapeutic interventions in MS
VJNeurology
How a better understanding of RAW and PIRA may improve outcomes & therapeutic interventions in MS
1:54
Investigating evobrutinib and other BTK inhibitors for the treatment of MS
VJNeurology
Investigating evobrutinib and other BTK inhibitors for the treatment of MS
3:05
The evolving understanding of the disease course in MS
VJNeurology
The evolving understanding of the disease course in MS
1:49
The importance of a multi-disciplinary team in MS lifestyle management
VJNeurology
The importance of a multi-disciplinary team in MS lifestyle management
1:42
Disability accrual in MS: RAW versus PIRA
VJNeurology
Disability accrual in MS: RAW versus PIRA
1:58
The clinical significance of a prodromal phase in MS
VJNeurology
The clinical significance of a prodromal phase in MS
3:35
Lower cognitive performance before MS symptom onset: a Norweigan study
VJNeurology
Lower cognitive performance before MS symptom onset: a Norweigan study
1:57
The concept of an MS prodomal phase and how it has long been neglected
VJNeurology
The concept of an MS prodomal phase and how it has long been neglected
1:29
The impact of dietary patterns on MS: what remains unknown
VJNeurology
The impact of dietary patterns on MS: what remains unknown
2:08
Barriers to the treatment of MS in the MENA region
VJNeurology
Barriers to the treatment of MS in the MENA region
2:55
Adverse events associated with natalizumab in MS and advice on mitigating them
VJNeurology
Adverse events associated with natalizumab in MS and advice on mitigating them
1:18
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS
VJNeurology
Natalizumab versus anti-CD20 monoclonal antibodies in the treatment of MS
1:50
Updates to the McDonald criteria for the diagnosis of MS
VJNeurology
Updates to the McDonald criteria for the diagnosis of MS
2:38
The challenge of defining progression independent from relapse activity in MS
VJNeurology
The challenge of defining progression independent from relapse activity in MS
4:19